Evidence map›Paper›PMID 37814064›Full record

ArticleNature medicine2023

Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.

Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Rémy Duléry, Catherine Thieblemont and 19 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 16 institutions in 1 country.

Roch HouotDepartment of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, French Blood Establishment, Rennes, France. roch.houot@chu-rennes.fr.ORCID http://orcid.org/0000-0003-1729-8213
Emmanuel BachyDepartment of Hematology, Lyon Sud Hospital Center, INSERM U1111, Lyon, France.ORCID http://orcid.org/0000-0003-2694-7510
Guillaume CartronDepartment of Hematology, University Hospital of Montpellier, UMR-CNRS 5535, Montpellier, France.
François-Xavier GrosDepartment of Clinical Hematology and Cellular Therapy, University Hospital of Bordeaux, Bordeaux, France.ORCID http://orcid.org/0000-0001-8998-3039
Franck MorschhauserULR 7365 - GRITA, University Hospital of Lille, Lille, France.
Lucie ObericDepartment of Hematology, Cancer University Institute of Toulouse Oncopole, Toulouse, France.
Thomas GastinneDepartment of Hematology, University Hospital of Nantes, Nantes, France.
Pierre FeugierDepartment of Hematology, University Hospital of Nancy, INSERM 1256, University of Lorraine, Vandœuvre-lès-Nancy, France.
Rémy DuléryDepartment of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMR938, Paris, France.
Catherine ThieblemontDepartment of Hematology and Oncology, Saint-Louis Hospital, AP-HP, Paris, France.ORCID http://orcid.org/0000-0002-9941-2448
Magalie JorisDepartment of Hematology, University Hospital of Amiens, Amiens, France.
Fabrice JardinDepartment of Clinical Hematology, Henri Becquerel Center, INSERM U1245, Rouen, France.ORCID http://orcid.org/0000-0002-6804-7943
Sylvain ChoquetDepartment of Hematology, University Hospital Pitié Salpêtrière, AP-HP, Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0002-7791-0470
Olivier CasasnovasDepartment of Clinical Hematology, Dijon University Hospital, INSERM UMR1231, Dijon, France.
Gabriel BrisouDepartment of Hematology, Institut Paoli-Calmettes, Marseille, France.
Morgane CheminantDepartment of Clinical Hematology, Necker-Enfants Malades University Hospital, AP-HP, INSERM UMR1163, Paris, France.
Jacques-Olivier BayDepartment of Clinical Hematology and Cellular Therapy, Clermont-Ferrand University Hospital Center, Clermont-Ferrand, France.
Francisco Llamas GutierrezDepartment of Anatomopathology, University Hospital of Rennes, Rennes, France.
Cédric MenardFrench Blood Establishment and SITI Laboratory, UMR U1236, INSERM, University of Rennes, University Hospital Center of Rennes, Rennes, France.
Karin TarteFrench Blood Establishment and SITI Laboratory, UMR U1236, INSERM, University of Rennes, University Hospital Center of Rennes, Rennes, France.ORCID http://orcid.org/0000-0002-6809-917X
Marie-Hélène DelfauDepartment of Immunology, Henri Mondor Hospital, Créteil, France.
Cédric PortuguesDepartment of Biostatistics, LYSARC, Lyon-Sud Hospital, Pierre-Bénite, France.
Emmanuel IttiDepartment of Nuclear Medicine, Henri Mondor Hospital, Créteil, France.
Xavier Palard-NovelloDepartment of Nuclear Medicine, University of Rennes, CLCC Eugène Marquis, INSERM, Rennes, France.
Paul Blanc-DurandDepartment of Nuclear Medicine, CHU H. Mondor, U-PEC, AP-HP, Créteil, France.
Yassine Al TabaaScintidoc Nuclear Medicine Center, Montpellier, France.
Clément BaillyNantes-Angers Cancer Research Center CRCI2NA, University of Nantes, INSERM UMR1307, CNRS-ERL6075, Nantes, France.
Camille LaurentDepartment of Pathology, Cancer University Institute of Toulouse Oncopole, CHU Toulouse, CRCT INSERM U1037, Toulouse, France.ORCID http://orcid.org/0000-0002-5375-7512
François LemonnierLymphoid Malignancies Unit, Henri Mondor Hospital, Mondor Institute for Biomedical Research, INSERM U955, University Paris-Est, Créteil, France.
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRCentre National de la Recherche Scientifique · FRHôpitaux Universitaires Henri-Mondor · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Rennes · FRHôpital Necker-Enfants Malades · FRInstitut National Polytechnique de Toulouse · FRInstitut Pprime · FRInstitut universitaire du cancer de Toulouse Oncopole · FRSorbonne Université · FRUniversité Claude Bernard Lyon 1 · FRUniversité de Bordeaux · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37814064
PMCPMC10579050
OpenAlexW4387458485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.